iRhythm Holdings, Inc.

IRTC 10-Q · Q1 2026

IRTC Q1 2026 request

Playground key active
Request URL /api/financials?ticker=IRTC&year=2026&quarter=1
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric Q1 2026 Q1 2025 YoY
Revenue 199,390 158,677 +25.7%
Show Product Lines breakouts
CMS 51,389 38,112 +34.8%
Contracted third-party payors 106,804 83,802 +27.4%
Customer A 30,154 26,673 +13.1%
Non-contracted third-party payors 11,043 10,090 +9.4%
Cost of Revenue 58,037 49,461 +17.3%
Show Public Utilities Inventory breakouts
Printed Circuit Board Assemblies 5.5 3.9 +41.0%
Gross Profit 141,353 109,216 +29.4%
Research And Development Expense Excluding Acquired In Process Cost 21,358 21,519 -0.7%
Research And Development Asset Acquired Other Than Through Business Combination Written Off 296 296 0.0%
Show Legal Entity breakouts
BioIntelliSense, Inc. · Convertible Notes Payable 0.3 0.3 0.0%
Selling, General & Administrative 135,884 119,957 +13.3%
Operating Expenses 157,538 141,772 +11.1%
Operating Income -16,185 -32,556 +50.3%
Interest Income 4,879 4,919 -0.8%
Interest Expense -3,290 -3,273 -0.5%
Other Non-Operating Income (Expense) 1,163 875 +32.9%
Non-Operating Income (Expense) 2,752 2,521 +9.2%
Income Before Taxes -13,433 -30,035 +55.3%
Income Tax Expense (Benefit) 500 665 -24.8%
Net Income -13,933 -30,700 +54.6%
Show Equity Components breakouts
Retained Earnings -13,933 -30,700 +54.6%
EPS (Basic) -0.43 -0.97 +55.7%
EPS (Diluted) -0.43 -0.97 +55.7%
Wtd Avg Shares (Basic) 32,507 31,590 +2.9%
Wtd Avg Shares (Diluted) 32,507 31,590 +2.9%
Comprehensive Income -14,294 -30,722 +53.5%

Balance Sheet

Balance Sheet
Metric Q1 2026 Q1 2025 YoY
Current Assets
Cash & Cash Equivalents 240,146 375,278 -36.0%
Marketable Securities (Current) 309,474 145,311 +113.0%
Accounts Receivable 80,863 80,639 +0.3%
Inventory 23,800 14,336 +66.0%
Prepaid Expenses & Other Current Assets 26,275 20,449 +28.5%
Total Current Assets 680,558 636,013 +7.0%
Non-Current Assets
Property, Plant & Equipment 156,704 130,850 +19.8%
Operating Lease Right-of-Use Assets 40,324 46,171 -12.7%
Restricted Cash Noncurrent 8,358 8,358 0.0%
Goodwill 862 862 0.0%
Long Term Investments 72,860 62,745 +16.1%
Other Non-Current Assets 46,699 41,099 +13.6%
Total Assets 1,006,365 926,098 +8.7%
Current Liabilities
Accounts Payable 8,559 11,946 -28.4%
Accrued Liabilities 102,342 79,976 +28.0%
Deferred Revenue (Current) 4,056 3,282 +23.6%
Operating Lease Liability Current 16,793 16,140 +4.0%
Total Current Liabilities 131,750 111,344 +18.3%
Non-Current Liabilities
Other Non-Current Liabilities 907 8,727 -89.6%
Operating Lease Liabilities 62,185 72,125 -13.8%
Total Liabilities 845,155 839,433 +0.7%
Other Liabilities
Convertible Long Term Notes Payable 650,313 647,237 +0.5%
Stockholders' Equity
Common Stock 33 32 +3.1%
Additional Paid In Capital Common Stock 1,003,514 901,085 +11.4%
Accumulated Other Comprehensive Income 42 143 -70.6%
Retained Earnings -817,379 -789,595 -3.5%
Treasury Stock Common Value -25,000 -25,000 0.0%
Total Stockholders' Equity 161,210 86,665 +86.0%
Show Equity Components breakouts
Accumulated Other Comprehensive Income 42 143 -70.6%
Additional Paid In Capital 1,003,514 901,085 +11.4%
Common Stock 33 32 +3.1%
Retained Earnings -817,379 -789,595 -3.5%
Treasury Stock Common -25,000 -25,000 0.0%
Total Liabilities & Equity 1,006,365 926,098 +8.7%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q1 2026 YTD Q1 2025 YoY
Operating Activities
Net Income -13,933 -30,700 +54.6%
Depreciation And Amortization 5,042 5,210 -3.2%
Stock-Based Compensation 21,491 23,344 -7.9%
Accretion Amortization Of Discounts And Premiums Investments -730 -619 -17.9%
Operating Lease Right Of Use Asset Amortization Expense 1,503 1,393 +7.9%
Amortization Of Debt Discount Premium 809 794 +1.9%
Equity Securities Fv Ni Gain Loss -1,447 -843 -71.6%
Provision For Credit Losses And Contractual Allowance 27,844 29,427 -5.4%
Other Operating Activities Cash Flow Statement 340 103 +230.1%
Change in Accounts Receivable -33,000 -30,125 -9.5%
Change in Inventory -2,424 -388 -524.7%
Change in Prepaid & Other Assets -4,613 -4,165 -10.8%
Increase Decrease In Other Noncurrent Assets -1,981 729 -371.7%
Change in Accounts Payable -22,522 -489 -4505.7%
Change in Deferred Revenue -145 350 -141.4%
Increase Decrease In Operating Lease Liabilities -2,703 -2,208 -22.4%
Net Cash from Operations -26,173 -7,891 -231.7%
Depreciation & Amortization 5 5.2 -3.8%
Investing Activities
Capital Expenditures -6,905 -9,419 +26.7%
Payments To Acquire Marketable Securities -94,030 -34,320 -174.0%
Proceeds From Maturities Prepayments And Calls Of Marketable Securities 132,650 5,600 +2268.8%
Payments To Acquire Strategic Investments -1,500
Net Cash from Investing 30,215 -38,139 +179.2%
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount 1,118 1,406 -20.5%
Financing Activities
Proceeds From Stock Plans 149 1,729 -91.4%
Net Cash from Financing 149 1,729 -91.4%
Amortization of Financing Costs (Q)
Show Debt Instrument breakouts
Convertible Notes Due 2029 · Convertible Debt 809 793 +2.0%
Supplemental
Interest Paid 4,959 4,959 0.0%
Income Taxes Paid -90 390 -123.1%
Operating Lease Payments 4,133 3,864 +7.0%
Unpaid Capital Expenditures 2,531 132 +1817.4%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations -57 -18 -216.7%
Net Change in Cash 4,134 -44,319 +109.3%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 248,504 383,636 -35.2%

Values in thousands USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key